Xbrane Biopharma Plans to Continue Phase III Trial of its Xlucane® (Ranibizumab) Biosimilar Product

Published date24 April 2020
Subject MatterClinical Trials,Prescription Drugs,Biosimilars,Pharmaceutical Industry,Coronavirus/COVID-19
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT